Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash
Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash
Nanoviricides第二季度每股收益爲0.18美元（0.18美元），低於同比增長0.15美元；截至2023年12月31日，我們的現金和現金等價物流動資產餘額約爲531萬美元。其他協議又帶來了約250萬美元的可用現金
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.18) per share. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year.
Nanoviricides（美國證券交易所股票代碼：NNVC）報告的季度虧損爲每股0.18美元。這比去年同期每股虧損0.15美元（0.15美元）下降了20％。